Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age

NCT05871970 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
38
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Protara Therapeutics